Literature DB >> 14689698

Pathogenesis and pathophysiology of yellow fever.

Thomas P Monath1, Alan D Barrett.   

Abstract

It will be apparent to the reader that there is much to learn about the pathogenesis of YF. The role of specific genes and molecular determinants of neurotropism and viscerotropism has been defined only partially. The availability of infectious clones and a small animal (hamster) model should allow dissection of virulence factors, which can then be tested in the more difficult monkey model. The marked differences between wild-type YF strains should be evaluated by evaluating the relationships between virulence and genome sequence. The role of cytokine dysregulation and endothelial injury in YF will be elucidated as access to patients and of patients to more sophisticated medical care improves. The number of cases of YF in unvaccinated travelers hospitalized after return from the tropics has unfortunately increased, but such cases afford unique opportunities to study the pathogenesis of renal failure, coagulopathy, vascular instability, and shock, as well as new treatment modalities. At the cellular level, there are also important opportunities for research on YF virus-cell receptor interactions, the control of apoptotic cell death, and the predilection for cells of the midzone of the liver lobule. The role of dendritic cells in the early stage of YF infection is deserving of study. Finally, the role of the immune response to infection, particularly cellular immunity, is poorly characterized, and the suggestion that immune clearance may aggravate the condition of the host during the period of intoxication should be evaluated in appropriate animal models.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14689698     DOI: 10.1016/s0065-3527(03)60009-6

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN: 0065-3527            Impact factor:   9.937


  46 in total

1.  Comparison of three neurotropic viruses reveals differences in viral dissemination to the central nervous system.

Authors:  Lauren N Luethy; Andrea K Erickson; Palmy R Jesudhasan; Mine Ikizler; Terence S Dermody; Julie K Pfeiffer
Journal:  Virology       Date:  2015-10-16       Impact factor: 3.616

2.  Incubation periods of Yellow fever virus.

Authors:  Michael A Johansson; Neysarí Arana-Vizcarrondo; Brad J Biggerstaff; J Erin Staples
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

Review 3.  The yellow fever 17D virus as a platform for new live attenuated vaccines.

Authors:  Myrna C Bonaldo; Patrícia C Sequeira; Ricardo Galler
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

4.  Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.

Authors:  Enoch Muyanja; Aloysius Ssemaganda; Pearline Ngauv; Rafael Cubas; Helene Perrin; Divya Srinivasan; Glenda Canderan; Benton Lawson; Jakub Kopycinski; Amanda S Graham; Dawne K Rowe; Michaela J Smith; Sharon Isern; Scott Michael; Guido Silvestri; Thomas H Vanderford; Erika Castro; Giuseppe Pantaleo; Joel Singer; Jill Gillmour; Noah Kiwanuka; Annet Nanvubya; Claudia Schmidt; Josephine Birungi; Josephine Cox; Elias K Haddad; Pontiano Kaleebu; Patricia Fast; Rafick-Pierre Sekaly; Lydie Trautmann; Denis Gaucher
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

5.  Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model.

Authors:  Justin G Julander; John D Morrey; Lawrence M Blatt; Kristiina Shafer; Robert W Sidwell
Journal:  Antiviral Res       Date:  2006-09-22       Impact factor: 5.970

6.  Transverse myelitis associated with yellow fever vaccination.

Authors:  Kyle D Bartol; Jose L Aguirre; Salvatore V Labruzzo; Russ P Henriet
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-03-26

7.  A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.

Authors:  F Guirakhoo; Z Zhang; G Myers; B W Johnson; K Pugachev; R Nichols; N Brown; I Levenbook; K Draper; S Cyrek; J Lang; C Fournier; B Barrere; S Delagrave; T P Monath
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Yellow fever virus infection in Syrian golden hamsters: relationship between cytokine expression and pathologic changes.

Authors:  Guangyu Li; Tao Duan; Xiaoyan Wu; Robert B Tesh; Lynn Soong; Shu-Yuan Xiao
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

9.  E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence.

Authors:  Eva Lee; Mario Lobigs
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

10.  A mouse model for studying viscerotropic disease caused by yellow fever virus infection.

Authors:  Kathryn C Meier; Christina L Gardner; Mikhail V Khoretonenko; William B Klimstra; Kate D Ryman
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.